Womens Health Investment Outlook 2026

Reasons for optimism –Strong demand: Women’s mental health remains significantly under-addressed, creating a large, underpenetrated market for scalable solutions. –Validated exits: Recent IPOs and acquisitions in digital mental health have validated liquidity pathways and demonstrated consolidation potential. –Proven ROI: Employer programmes show clear financial benefit, saving roughly $190 in medical costs for every $100 invested.90,91 –Technological innovation: AI-driven personalization, reproductive-health integration and improved user experience continue to enhance engagement and clinical efficacy. Points of caution for investors –Competition from generalists: Large-scale players dominate generic mental health. Women’s health-specific platforms will require deep integration with reproductive, hormonal and postpartum care. –Need for evidence: Longitudinal outcomes data remains limited, and validation through randomized trials will be key for sustained reimbursement and payer adoption. 3.5 Women-first longevity and wellness concierge services Current activity Women-first longevity and wellness concierge services in the US are bridging the long- standing gap between traditional primary care and personalized preventive medicine. More than 1 billion women globally are peri- or post- menopausal,92 yet most experience fragmented or insufficient care, driven by limited clinician training, stigma and the historical under-representation of women’s health in medical research.93 Women-first platforms are offering integrated clinical, hormonal and wellness management, with a global total addressable market of approximately $4.3 billion in 2025. Between 2020 and 2025, the women-first longevity sector raised approximately $400 million, with strong participation from venture, growth-stage and strategic investors. Nearly all capital has flowed to women’s health-specific platforms, underscoring that menopause and midlife care have evolved into a distinct, stand-alone investment category. Nearly 90% of investments have been private funding rounds. The NIH Office of Research on Women’s Health has integrated women’s health into SBIR and STTR solicitations, and the NIH has funded menopause and midlife health research (approximately $56 million in 2023).94,95 Women’s Health Investment Outlook 27